U.S. FDA Will Have Risk-Based Import Screening System Up And Running By Year's End
This article was originally published in PharmAsia News
Executive Summary
Computer glitches have prevented implementation in all 10 U.S. FDA districts of an information technology system that flags high-risk imports for possible inspection, but the system has been effective in the four districts where it has been rolled out, Commissioner Margaret Hamburg reported to a U.S. Congressional panel April 13
You may also be interested in...
U.S. Congressional Investigation Of Tainted Heparin Could Highlight Need For Import Safety Legislation - Or Not
A U.S. House of Representatives Energy and Commerce Committee investigation into who caused contamination of heparin supplies in 2007 and 2008, how it was done, and U.S. FDA's handling of the crisis, could revive interest in legislation designed to strengthen FDA's oversight of drugs and other medical products entering the U.S. from overseas
High-Risk Drug Imports To Be Delayed, FDA PREDICTs; Focus On Data Quality Can Avoid New 20 Percent Dragnet
An FDA information technology system designed to identify high-risk imports for possible inspection should speed U.S. entry for about 80 percent of FDA-regulated products coming into the country
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).